Package 63539-334-28

Brand: litfulo

Generic: ritlecitinib
NDC Package Sample

Package Facts

Identity

Package NDC 63539-334-28
Digits Only 6353933428
Product NDC 63539-334
Product ID 63539-334_5f5f631a-94b4-470e-939f-bbe09f204835
Description

28 CAPSULE in 1 BOTTLE (63539-334-28)

Marketing

Marketing Status
Marketed Since 2023-07-06
Brand litfulo
Generic ritlecitinib
Sample Package Yes

Linked Drug Pages (1)

Litfulo ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "5f5f631a-94b4-470e-939f-bbe09f204835", "openfda": {"unii": ["EAG4T1459K"], "rxcui": ["2641601", "2641607"], "spl_set_id": ["1882f799-61b0-4813-965a-4910c4ae419c"], "manufacturer_name": ["U.S. Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "28 CAPSULE in 1 BOTTLE (63539-334-28)", "package_ndc": "63539-334-28", "marketing_start_date": "20230706"}], "brand_name": "Litfulo", "product_id": "63539-334_5f5f631a-94b4-470e-939f-bbe09f204835", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Janus Kinase 3 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Tyrosine Kinase Inhibitors [MoA]"], "product_ndc": "63539-334", "generic_name": "ritlecitinib", "labeler_name": "U.S. Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Litfulo", "active_ingredients": [{"name": "RITLECITINIB TOSYLATE", "strength": "50 mg/1"}], "application_number": "NDA215830", "marketing_category": "NDA", "marketing_start_date": "20230706", "listing_expiration_date": "20261231"}